Research and surveillance activities include surveillance of vaccine preventable diseases, vaccination coverage and adverse events, vaccine safety and program evaluations and social research. NCIRS also provides technical support for the Australian Technical Advisory Group on Immunisation, including production of The Australian Immunisation Handbook.
Vaccine Safety Net Member
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.
We acknowledge that the National Centre for Immunisation Research & Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
* ‘Indigenous’ is used on these pages to incorporate all Aboriginal and Torres Strait Islander peoples.
Dr Meru Sheel and Prof Kristine Macartney explain why it is important to be immunised against diphtheria in this article published in the conversation.
Dr Sarah Sheridan from NCIRS and coauthors have discussed the effectiveness of two new enhanced influenza vaccines for over-65s that were introduced in 2018 in a perspective published by the Medical Journal of Australia (MJA). The researchers wrote in the MJA that, as the first country to publicly fund both new vaccines in the same population, Australia had a “unique opportunity” to conduct a head-to-head comparison of the two vaccines in the over-65s.